| 5-Azacytidine for the treatment of myelodysplastic syndromes J Krawczyk, N Keane, CL Freeman, R Swords, M O'Dwyer, FJ Giles Expert opinion on pharmacotherapy 14 (9), 1255-1268, 2013 | 13 | 2013 |
| 941 Stromal cell sialylation suppresses T cells in inflammatory tumour microenvironments: a new tumour stromal cell immune checkpoint? O Treacy, H Egan, K Lynch, N Leonard, K De Veirman, K Vanderkerken, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 1 | 2021 |
| A case series of sixth nerve palsy associated with intracranial plasmacytoma J Krawczyk, T Meenaghan, M Kelly, N Ansar, T Murphy, B MacDonagh, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 623-623, 2009 | 1 | 2009 |
| A multi-centre retrospective analysis of rituximab use in immune thrombocytopenia purpura (ITP) in the Republic of Ireland DJ Okeeffe, A Burke, S Mc Pherson, M Khan, Y Mahdi, M Gleeson, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 9, 788-788, 2011 | | 2011 |
| A Novel High-Throughput Screening Platform Identifies Itaconate Derivatives from Marine Penicillium antarcticum as Inhibitors of Mesenchymal Stem Cell … P Marchese, N Mahajan, E O’Connell, H Fearnhead, M Tuohy, ... Marine Drugs 18 (4), 192, 2020 | 14 | 2020 |
| A novel molecular assay using hybridisation probes and melt curve analysis for CALR exon 9 mutation detection in myeloproliferative neoplasms T Keaney, L O'Connor, J Krawczyk, MA Abdelrahman, AH Hayat, ... Journal of Clinical Pathology 70 (8), 662-668, 2017 | 2 | 2017 |
| A NOVEL, MULTI-SITE GMP PROTOCOL TO MANUFACTURE PROSPECTIVELY-ISOLATED, ALLOGENEIC BONE MARROW MSCS FOR A PHASE 1B CLINICAL TRIAL IN PROGRESSIVE DIABETIC KIDNEY DISEASE H Roelofs, E Steeneveld, O Pedrini, J Golay, A Duffy, V McInerney, ... CYTOTHERAPY 24 (5), S51-S51, 2022 | | 2022 |
| A phase II multi-center study of lenalidomide, subcutaneous bortezomib and dexamethasone (RsqVD) in Newly Diagnosed Multiple Myeloma-Ctrial-IE (ICORG) 13-17 Study P O'Gorman, ME O'Dwyer, O Gilligan, J Quinn, M Coyne, J Krawczyk, ... Blood 128 (22), 2117, 2016 | 2 | 2016 |
| A Single Centre Analysis of Spectra Optia Stem Cell Collection Data from Multiple Myeloma and Lymphoma Patients, with and without Plerixafor J Buckley, J Krawczyk, FN Chonchubhair, N Besson, M Tarpey, M Murray, ... Blood 124 (21), 3848, 2014 | 1 | 2014 |
| A Validated and Licensed Method of Bone Marrow Aspirate Procurement to Support Advanced Therapy Investigational Medicinal Product (ATIMP) Manufacture S Naughton, V McInerney, SA Mohamed, S Finnerty, M Tarpey, A Hayat, ... Blood 130, 5460, 2017 | | 2017 |
| AKT as a therapeutic target in multiple myeloma NA Keane, SV Glavey, J Krawczyk, M O’Dwyer Expert opinion on therapeutic targets 18 (8), 897-915, 2014 | 52 | 2014 |
| Arresting Resistance: Multi-Drug Resistant Organisms in Autologous Stem Cell Transplant Recipients at an Irish Tertiary Referral Centre M Gurney, A Hayat, M O'Dwyer, J Krawczyk Clinical Lymphoma, Myeloma and Leukemia 19, S333-S334, 2019 | | 2019 |
| Audit of compliance with the British Committee for Standards in Haematology (BCSH) revised guidelines for the diagnosis and assessment of treatment response of hairy cell … K Velazquez-Kennedy, C Crowe, B Craven, J Walsh, C Prendergast, ... Irish Journal of Medical Science (1971-) 186, 345-347, 2017 | | 2017 |
| Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities SA Mohamed, L Howard, V McInerney, A Hayat, J Krawczyk, S Naughton, ... Cytotherapy 22 (6), 313-321, 2020 | 33 | 2020 |
| Autologous mesenchymal stem cells as a novel therapy for no-option critical limb ischemia: Preliminary results of a phase 1 study S Mohamed, V McInerney, A Dunne, A Hayat, J Krawczyk, S Naughton, ... Cytotherapy 19 (5), S198, 2017 | 1 | 2017 |
| Avapritinib Inhibitor J Krawczyk, N Keane, R Swords, M O’Dwyer, CL Freeman, FJ Giles Expert Opin. Investig. Drugs 22 (10), 1315-1327, 2013 | | 2013 |
| Beyond DNA damage: exploring the immunomodulatory effects of cyclophosphamide in multiple myeloma D Swan, M Gurney, J Krawczyk, AE Ryan, M O’Dwyer Hemasphere 4 (2), e350, 2020 | 36 | 2020 |
| CALR Mutation Underlying Silent Stroke R Faryal, LL Tokar, SE Langabeer, J Krawczyk TH Open 5 (02), e174-e175, 2021 | | 2021 |
| Case of recurrent Achromobacter xylosoxidans bacteraemia and PICC (peripherally-inserted central catheter) line infection in an immunocompromised patient E Houlihan, M Lucey, A Pandian, B Hanahoe, F Higgins, N DeLappe, ... Infection Prevention in Practice 4 (1), 100202, 2022 | 5 | 2022 |
| Choroba żylno-okluzyjna wątroby-istotne powikłanie po transplantacji komórek macierzystych hematopoezy A Skotnicki, J Krawczyk Przegląd Lekarski 58 (11), 2001 | | 2001 |
Michael O'DwyerHaematology在 nuigalway.ie 的电子邮件经过验证
